INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
Page 1678 of 1855
← PrevNext →
traded Dec 9, 2025
+1d
SEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
7,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Grant or award
A—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
TE
Torstad ElisabethDirector
ULSUL Solutions Inc.
Grant or award
A—
8 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
48.8K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
CS
Chapin Linda SEVP & CHRO
ULSUL Solutions Inc.
Grant or award
A—
4 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
UA
Uggetti AlbertoEVP & CCO
ULSUL Solutions Inc.
Grant or award
A—
3 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SG
Schjotz GitteSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
8 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
HF
Hecker FriedrichDirector
ULSUL Solutions Inc.
Grant or award
A—
4 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
UA
Uggetti AlbertoEVP & CCO
ULSUL Solutions Inc.
Grant or award
A—
4 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
DA
Dadakis AlexSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
26 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
DA
Dadakis AlexSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
8 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
40.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Tax withholding
F$42K
182 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
MA
Marathe AjayChief Operating Officer
ENVXEnovix Corp
Tax withholding
F$13K
1,490 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
MB
MacDonald Neil BEVP, GM, Server
HPEHewlett Packard Enterprise Co
Grant or award
A—
146.7K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
VJ
Vittiglio JosephChief Business & Legal Officer
PEPGPepGen Inc.
Grant or award
A—
160.0K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
1,250 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Grant or award
A—
25.0K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HH
Hancock Lynn HSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
5 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
DS
Dreyer ScottEVP & Chief Commercial Officer
COLLCOLLEGIUM PHARMACEUTICAL, INC
Option exercise · 10b5-1 plan
M$280K
17.6K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
13.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
UA
Uggetti AlbertoEVP & CCO
ULSUL Solutions Inc.
Grant or award
A—
5 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
8,990 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
GA
Genovesi John ASee Remarks
ULSUL Solutions Inc.
Grant or award
A—
6 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
1,000 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.4K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
CA
Chakravarthy ArthiChief Legal Officer
ENVXEnovix Corp
Tax withholding
F$8,107
934 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
TE
Torstad ElisabethDirector
ULSUL Solutions Inc.
Grant or award
A—
4 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
5,331 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SG
Schjotz GitteSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
8 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
8,831 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
44.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
HH
Hancock Lynn HSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
3 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SM
Sondel MichaelCAO (principal acct. officer)
ADIANALOG DEVICES INC
Grant or award
A—
203 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence